Advertisement – Charles Stanley mid banner
Advertisement: EBCam mid banner
Advertisement: Cambridge Network mid banner
Advertisement: Kao Data Centre mid banner
Advertisement: Hewitsons mid banner
CBM light up lives mid banner advert
Advertisement: Mogrify mid banner
Advertisement: Howard Group mid banner
Barr Ellison Solicitors – commercial property
Advertisement: TTP
Advertisement: RSM
ARM Innovation Hub
Advertisement: EY Mid banner
Advertisement: CJBS mid banner
Advertisement: Wild Knight Vodka
Mid banner advertisement: BDO
Advertisement: S-Tech mid banner 3
Advertisement: Simpsons Creative
21 December, 2020 - 23:11 By Tony Quested

Harlow becomes home to new NVIDIA supercomputer

US technology giant NVIDIA, which expects to complete its $40 billion acquisition of Cambridge superchip architect Arm in 2021, has decided to site its powerful new supercomputer at the KAO Data Centre in Harlow.

It is one of several initiatives NVIDIA is unleashing as part of its swoop for Arm and could become a reality before the end of 2020. The supercomputer will be used for AI-powered drug discovery and analysis of NHS datasets.

Another global play will see NVIDIA and Arm develop a state-of-the-art AI centre of excellence in Cambridge alongside a number of synergistic initiatives.

Business Weekly has been promoting the KAO Data Centre in Harlow for much of 2020 and recently co-hosted a round table involving Arm and other influencers to shape the thinking around the adoption of high performance and advanced computing over the next decade.

The Times newspaper has reported that the Cambridge-1 supercomputer could be officially unveiled by PM Boris Johnson and Health Secretary Matt Hancock early next year.

As previously reported, NVIDIA says the supercomputer will trigger major new initiatives in healthcare and drug discovery, harnessing Artificial Intelligence.

Cambridge headquartered AstraZeneca and GSK, which partner and invest in a number of Cambridge life science endeavours are keen to embrace the power of Cambridge-1 for a range of bleeding edge research ventures. This week, GSK announced investment in Cambridge startup Adestria with an eye to a long term drug discovery collaboration.

NVIDIA also expects to roll out a number of other advanced technology enterprises; it is understood that these do not depend solely on being allowed to acquire Arm – which is great news for the Cambridge Science & Technology Cluster.

KAO Data Centre is unable to comment under the terms of the deal with NVIDIA, US sources have told Business Weekly.

Newsletter Subscription

Stay informed of the latest news and features